HDL metabolism in diabetes
1987; Wiley; Volume: 3; Issue: 3 Linguagem: Inglês
10.1002/dmr.5610030303
ISSN1099-0895
AutoresY.‐D. I. Chen, C‐Y Jeng, Gerald M. Reaven,
Tópico(s)Diet, Metabolism, and Disease
ResumoDiabetes/Metabolism ReviewsVolume 3, Issue 3 p. 653-668 Lipid Metabolism HDL metabolism in diabetes Y.-D. I. Chen, Y.-D. I. Chen Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this authorC-Y Jeng, C-Y Jeng Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this authorG. M. Reaven, G. M. Reaven Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this author Y.-D. I. Chen, Y.-D. I. Chen Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this authorC-Y Jeng, C-Y Jeng Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this authorG. M. Reaven, G. M. Reaven Department of Medicine, Stanford University School of Medicine, and the Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, California 94304Search for more papers by this author First published: July 1987 https://doi.org/10.1002/dmr.5610030303Citations: 24AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Taylor KG, Wright AD, Carter TJN, Valente AJ, Betts SA, and Matthews KA: High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes. Diabetologia 20: 535–539, 1981. 10.1007/BF00252761 CASPubMedWeb of Science®Google Scholar 2 Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, and Bierman EL: Abnormal composition of high density lipoprotein in non-insulin dependent diabetes. Diabetes 31: 126–131, 1982. 10.2337/diab.31.2.126 CASPubMedWeb of Science®Google Scholar 3 Taskinen M-R, Nikkilä EA, Kuusi T, and Harno K: Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-dependent) diabetes associated with obesity. Diabetologia 22: 46–50, 1982. 10.1007/BF00253869 PubMedWeb of Science®Google Scholar 4 Uusitupa M, Siitonen O, Voutilainen E, Aro A, Hersio K, Pyörälä K, Penttilä I, and Ehnholm C: Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (Type II) diabetic patients with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 9: 17–22, 1986. 10.2337/diacare.9.1.17 CASPubMedWeb of Science®Google Scholar 5 Pan XR, Waiden CE, Warnick GR, Hu SX, Albers JJ, Cheung M, and Bierman EL: Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls. Diabetes Care 9: 395–400, 1986. 10.2337/diacare.9.4.395 CASPubMedWeb of Science®Google Scholar 6 Jiao S, Kameda K, Matsuzawa Y, Kubo M, Nonaka K, and Tarui S: Influence of endogenous hyperinsulinemia on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance. Atherosclerosis 60: 279–286, 1986. 10.1016/0021-9150(86)90175-9 CASPubMedWeb of Science®Google Scholar 7 Lopes-Virella MFL, Stone PG, and Colwell JA: Serum high density lipoprotein in diabetic patients. Diabetologia 13: 285–291, 1977. 10.1007/BF01223267 CASPubMedWeb of Science®Google Scholar 8 Gordon T, Castelli WP, Hjortland MC, Kannel WB, and Dawber TR: Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann Intern Med 87: 393–397, 1977. 10.7326/0003-4819-87-4-393 PubMedWeb of Science®Google Scholar 9 Kennedy AL, Lappin TRJ, Lavery TD, Hadden DR, Weaver JA, and Montgomery DA: Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br Med J 2: 1191–1194, 1978. 10.1136/bmj.2.6146.1191 CASPubMedWeb of Science®Google Scholar 10 Calvert GD, Graham JJ, Mannik T, Wise PH, and Yeates RA: Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 2: 66–68, 1978. 10.1016/S0140-6736(78)91380-6 CASPubMedWeb of Science®Google Scholar 11 Lisch H-J and Sailer S: Lipoprotein patterns in diet, sulphonylurea, and insulin-treated diabetes. Diabetologia 20: 118–122, 1981. 10.1007/BF00262013 CASPubMedWeb of Science®Google Scholar 12 Berry EM and Bar-On H: Comparison of sulphonylurea and insulin treatment on lipid levels in maturity onset diabetic men and women. Israel J Med Sci 17: 384–387, 1981. CASPubMedWeb of Science®Google Scholar 13 Jialal I, Joubert SM, and Asmal AC: Cholesterol, triglyceride and high-density lipoprotein cholesterol levels in non-insulin-dependent diabetes in the young. S Afr Med J 61: 393–395, 1982. CASPubMedWeb of Science®Google Scholar 14 Schmitt JK, Poole JR, Lewis SB, Shore VG, Maman A, Baer RM, and Forsham PH: Hemoglobin A1 correlates with the ratio of low- to high-density-lipoprotein cholesterol in normal weight type II diabetes. Metabolism 31: 1084–1089, 1982. 10.1016/0026-0495(82)90156-1 CASPubMedWeb of Science®Google Scholar 15 Greenfield MS, Doberne L, Rosenthal M, Vreman HJ, and Reaven GM: Lipid metabolism in non-insulin-dependent diabetes mellitus. Arch Intern Med 142: 1498–1500, 1982. CASPubMedWeb of Science®Google Scholar 16 Barrett-Conner E, Wiztum J, and Holdbrook M: A community study of high density lipoproteins in adult noninsulin-dependent diabetes. Am J Epidemiol 117: 186–192, 1983. PubMedWeb of Science®Google Scholar 17 Waiden CE, Knopp RH, Wahl PW, Beach KW, and Strandness E: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 311: 953–959, 1984. 10.1056/NEJM198410113111505 PubMedWeb of Science®Google Scholar 18 Briones ER, Mao SJT, Palumbo PJ, O'Fallon WM, Chenoweth W, and Kottke BA: Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetes. Metabolism 33: 42–49, 1984. 10.1016/0026-0495(84)90160-4 CASPubMedWeb of Science®Google Scholar 19 Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, and Penttila I: Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetes. Metabolism 34: 715–720, 1985. 10.1016/0026-0495(85)90020-4 CASPubMedWeb of Science®Google Scholar 20 Fuh MM-T and Shieh S-M: Association of low plasma high density lipoprotein (HPL)-cholesterol concentration with documented coronary artery disease in males with non-insulin-dependent Diabetes Mellitus. Horm Metab Res 19: 267–270, 1987. 10.1055/s-2007-1011795 CASPubMedWeb of Science®Google Scholar 21 Ballantyne D, White C, Strevens EA, Lawrie TDV, Lorimer AR, Manderson WG, and Morgan HG: Lipoprotein concentrations in untreated adult onset diabetes mellitus and the relationship of the fasting plasma triglyceride concentration to insulin secretion. Clin Chim Acta 78: 323–329, 1977. 10.1016/0009-8981(77)90323-0 CASPubMedWeb of Science®Google Scholar 22 Mattock MB, Fuller JH, Maude PS, and Keen H: Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 34: 437–449, 1979. 10.1016/0021-9150(79)90068-6 CASPubMedWeb of Science®Google Scholar 23 Simpson RW, Carter RD, Moore RA, and Penfold WAF: Diurnal changes in plasma lipoproteins in normal subjects and diabetics. Diabetologia 18: 35–40, 1980. 10.1007/BF01228299 CASPubMedWeb of Science®Google Scholar 24 Durrington PN: Serum high density lipoprotein cholesterol in diabetes mellitus: An analysis of factors which influence its concentration. Clin Chim Acta 104: 11–23, 1980. 10.1016/0009-8981(80)90130-8 CASPubMedWeb of Science®Google Scholar 25 Howard BC, Savage PJ, Bennion LJ, and Bennett PH: Lipoprotein composition in diabetes mellitus. Atherosclerosis 30: 153–162, 1978. 10.1016/0021-9150(78)90058-8 CASPubMedWeb of Science®Google Scholar 26 Albrink MJ, Krauss RM, and Lindgren FT: Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 15: 668–676, 1980. 10.1007/BF02534017 CASPubMedWeb of Science®Google Scholar 27 Philips NR, Havel RJ, and Kane JP: Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides: Association with adiposity and the consumption of ethanol, tobacco and beverages containing caffeine. Arteriosclerosis 1: 13–24, 1981. 10.1161/01.ATV.1.1.13 PubMedWeb of Science®Google Scholar 28 Schaeffer EJ, Anderson DW, Brewer HB Jr., et al: Plasma triglycerides in regulation of HDL cholesterol levels. Lancet 2: 391–393, 1978. 10.1016/S0140-6736(78)91863-9 CASPubMedWeb of Science®Google Scholar 29 National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057, 1979. 10.2337/diab.28.12.1039 PubMedWeb of Science®Google Scholar 30 Albrink MJ: Dietary and drug treatment of hyperlipidemia in diabetes. Diabetes 23: 913–918, 1974. 10.2337/diab.23.11.913 CASPubMedWeb of Science®Google Scholar 31 Greenfield M, Kolterman O, Olefsky JM, and Reaven GM: Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 18: 441–446, 1980. 10.1007/BF00261698 CASPubMedWeb of Science®Google Scholar 32 Lewis B: Metabolism of plasma cholesterol in The Hyperlipidaemias. Clinical and Laboratory Practice. Oxford, Blackwell Scientific Publications, 1976, pp 93–119. Google Scholar 33 Tall AR and Small DM: Plasma high density lipoproteins. N Engl J Med 299: 1232, 1978. 10.1056/NEJM197811302992207 CASPubMedWeb of Science®Google Scholar 34 Fuller JH, Pinney S, Jarrett RJ, Kilbourn K, and Keen H: Plasma lipids in a London population and their relationship to other risk factors for coronary heart disease. Br Heart J 40: 170–176, 1978. 10.1136/hrt.40.2.170 CASPubMedWeb of Science®Google Scholar 35 Schonfeld G, Birge C, Miller PJ, Kessler G, and Santiago J: Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes 23: 827–833, 1974. 10.2337/diab.23.10.827 CASPubMedWeb of Science®Google Scholar 36 Sosenko JM, Breslow JL, Miettinen OS, and Gabbay KH: Hyperglycemia and plasma lipid levels. N Engl J Med 302: 650–654, 1980. 10.1056/NEJM198003203021202 CASPubMedWeb of Science®Google Scholar 37 Pollak A, Widhalm K, Havelec L, Frisch H, and Schober E: Glycosylated hemoglobin (HbA1c) and plasma lipoproteins in juvenile onset diabetes mellitus. Acta Paediatr Scand 69: 475–479, 1980. 10.1111/j.1651-2227.1980.tb07117.x CASPubMedWeb of Science®Google Scholar 38 Eckel RH, Alberts JJ, Cheung MC, Wahl W, Lindgren FT, and Bierman EL: High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 30: 132–138, 1981. 10.2337/diabetes.30.2.132 CASPubMedWeb of Science®Google Scholar 39 Mattock MB, Salter AM, Fuller JH, Omer T, R-El-Gohari, Redmond SD, and Keen H: High density lipoprotein subtractions in insulin-dependent diabetic and normal subjects. Atherosclerosis 45: 67–79, 1982. 10.1016/0021-9150(82)90172-1 CASPubMedWeb of Science®Google Scholar 40 Winocour PH, Darrington PN, Ishola M, and Anderson DC: Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet 1: 1176–1178, 1986. 10.1016/S0140-6736(86)91159-1 CASPubMedWeb of Science®Google Scholar 41 Nikkilä EA and Hormila P: Serum lipids and lipoproteins in insulin-treated diabetes. Diabetes 27: 1078–1086, 1978. 10.2337/diab.27.11.1078 CASPubMedWeb of Science®Google Scholar 42 Klujber L, Molnar D, Kardos M, Jaszai V, Soltesz Gy, and Mestyan J: Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children. Eur J Pediatr 132: 289–297, 1979. 10.1007/BF00496852 CASPubMedWeb of Science®Google Scholar 43 Lopes-Virella MF, Wohltmann HJ, Loadholt CB, and Buse MG: Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: Relationship with control. Diabetologia 21: 216–223, 1981. 10.1007/BF00252657 PubMedWeb of Science®Google Scholar 44 Gofman JW, DeLalla O, Glazier F, Freeman NK, Lindgren FT, Nichols AV, Strisower B, and Tamplin AR: The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. Plasma 2: 413–484, 1954. Google Scholar 45 Weidman SW, Ragland JB, Fisher JN Jr., Kitabchi AE, and Sabesin SM: Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: Evidence for a change in high density lipoprotein composition during treatment. J Lipid Res 23: 171–182, 1982. CASPubMedWeb of Science®Google Scholar 46 Kolb FO, De Lalla OF, and Gofman JW: The hyperlipemias in disorders of carbohydrate metabolism: Serial lipoprotein studies in diabetic acidosis with xanthomatosis and in glycogen storage disease. Metabolism 4: 310–317, 1955. CASPubMedWeb of Science®Google Scholar 47 Taskinen M-R and Nikkilä EA: Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia 17: 351–356, 1979. 10.1007/BF01236268 CASPubMedWeb of Science®Google Scholar 48 Eisenberg S, Patsch JR, Olivercrona T, et al: Effects of lipolysis on human high density lipoproteins (HDL). Circulation 58: 15A, 1978. Google Scholar 49 Patsch JR, Gott AM Jr., Olivercrona T, and Eisenberg S: Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 75: 4519–4523, 1978. 10.1073/pnas.75.9.4519 CASPubMedWeb of Science®Google Scholar 50 Kissebah AH, Adams PW, and Wynn V: Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (Phenformin). Diabetologia 10: 119–130, 1974. 10.1007/BF01219667 CASPubMedWeb of Science®Google Scholar 51 Golay A, Zech L, Shi M-Z, Chiou Y-AM, Reaven GM, and Chen Y-DI: High density lipoprotein (HDL) metabolism in non-insulin dependent diabetes mellitus: Measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab, in press. Google Scholar 52 Harno K, Nikkilä EA, and Kuusi T: Plasma HDL-cholesterol and postheparin plasma hepatic endothelial lipase (HL) activity: Relationship to obesity and non-insulin dependent diabetes (NIDDM). Diabetologia 19: 281, 1980. Web of Science®Google Scholar 53 Abrams JJ, Ginsberg H, and Grundy SM: Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 31: 903–910, 1982. 10.2337/diab.31.10.903 CASPubMedWeb of Science®Google Scholar 54 Fielding CJ, Reaven GM, Liu G, and Fielding PE: Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 81: 2512–2516, 1984. 10.1073/pnas.81.8.2512 CASPubMedWeb of Science®Google Scholar 55 Hornick CA and Fellmeth BD: High density lipoprotein cholesterol, insulin and obesity in Samoans. Atherosclerosis 39: 321–328, 1981. 10.1016/0021-9150(81)90019-8 CASPubMedWeb of Science®Google Scholar 56 Stalder M, Pometta D, and Suenram A: Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy man. Diabetologia 21: 544–548, 1981. CASPubMedWeb of Science®Google Scholar 57 Orchard TJ, Becker DJ, Bates M, Kuller LH, and Drash AL: Plasma insulin and lipoprotein concentrations—an atherogenic association? Am J Epidemiol 118: 326–337, 1983. 10.1093/oxfordjournals.aje.a113639 CASPubMedWeb of Science®Google Scholar 58 Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A, and Butturini U: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259–266, 1985. 10.1016/0021-9150(85)90105-4 CASPubMedWeb of Science®Google Scholar 59 Reaven GM, Bernstein R, Davis B, and Olefsky JM: Non-ketotic diabetes mellitus: Insulin deficiency or insulin resistance? Am J Med 60: 80–88, 1976. 10.1016/0002-9343(76)90536-2 PubMedWeb of Science®Google Scholar 60 Reaven GM and Olefsky JF: Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia 13: 201–206, 1977. 10.1007/BF01219700 CASPubMedWeb of Science®Google Scholar 61 Reaven GM: Insulin-independent diabetes mellitus: Metabolic characteristics. Metabolism 29: 445–454, 1980. 10.1016/0026-0495(80)90170-5 CASPubMedWeb of Science®Google Scholar 62 Hollenbeck CB, Chen N, Chen Y-DI, and Reaven GM: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33: 460–463, 1984. 10.2337/diab.33.5.460 CASPubMedWeb of Science®Google Scholar 63 DeFronzo RA, Simonson D, and Ferrannini E: Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23: 313–319, 1982. 10.1007/BF00253736 CASPubMedWeb of Science®Google Scholar 64 Chen Y-DI, Golay A, Swislocki ALM, and Reaven GM: Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64: 17–21, 1987. 10.1210/jcem-64-1-17 CASPubMedWeb of Science®Google Scholar 65 Golay A, Zech L, Shi M-Z, Jeng C-Y, Chiou Y-AM, Reaven GM, and Chen Y-DI: Role of insulin in regulation of high density lipoprotein metabolism. J Lipid Res 28: 10–18, 1987. CASPubMedWeb of Science®Google Scholar 66 Weiland D, Mondon CE, and Reaven GM: Evidence for multiple causality in the development of diabetic hypertriglyceridemia. Diabetologia 18: 335–340, 1980. 10.1007/BF00251016 CASPubMedWeb of Science®Google Scholar 67 Nikkilä EA, Huttunen JK, and Ehnholm C: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus: Relationship to plasma triglyceride metabolism. Diabetes 26: 11–21, 1977. CASPubMedWeb of Science®Google Scholar 68 Schonfeld G, Bell E, and Alpers DH: Intestinal apoproteins during fat absorption. J Clin Invest 61: 1539–1550, 1978. 10.1172/JCI109074 CASPubMedWeb of Science®Google Scholar 69 Glickman RM, Green PHR, Lees RS, et al: Apoprotein A-1 synthesis in normal intestinal mucosa and in Tangier disease. N Engl J Med 299: 1424–1427, 1978. 10.1056/NEJM197812282992602 CASPubMedWeb of Science®Google Scholar 70 Green PHR, Tall AR, and Glickman RM: Rat intestine secrets discoid high density lipoprotein. J Clin Invest 61: 528–534, 1978. 10.1172/JCI108963 CASPubMedWeb of Science®Google Scholar 71 Hamilton RJ, Williams MC, Fielding CJ, et al: Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 58: 667–680, 1976. 10.1172/JCI108513 CASPubMedWeb of Science®Google Scholar 72 Marsh JB: Apoproteins of the lipoproteins in a nonrecirculating perfusate of rat liver. J Lipid Res 17: 85–90, 1976. CASPubMedWeb of Science®Google Scholar 73 Misra DP, Staddon G, Powell N, Misra J, and Crook D: Lecithin: cholesterol acyl-transferase activity in diabetes mellitus and the effect of insulin in these cases. Clin Chim Acta 56: 83–89, 1974. 10.1016/0009-8981(74)90195-8 CASPubMedWeb of Science®Google Scholar 74 Miller GJ and Miller NE: Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1: 16–19, 1975. 10.1016/S0140-6736(75)92376-4 CASPubMedWeb of Science®Google Scholar 75 Castelli WP, Doyle JT, Gordon T, et al: HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation 55: 767–772, 1977. 10.1161/01.CIR.55.5.767 CASPubMedWeb of Science®Google Scholar 76 Reckless JPD, Betteridge DJ, Wu P, Payne B, and Galton DJ: High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1: 883–886, 1978. 10.1136/bmj.1.6117.883 CASPubMedWeb of Science®Google Scholar 77 Welborn TA, Knuiman M, McCann V, Stanton K, and Constable IJ: Clinical macrovascular disease in Caucasoid diabetic subjects: Logistic regression analysis of risk variables. Diabetologia 27: 568–573, 1984. 10.1007/BF00276969 CASPubMedWeb of Science®Google Scholar 78 Howard BV, Savage PJ, Nagulesparan M, Bennion LJ, Davis M, and Bennett PH: Changes in plasma lipoproteins accompanying diet therapy in obese diabetics. Ahterosclerosis 33: 445–456, 1979. 10.1016/0021-9150(79)90037-6 CASPubMedWeb of Science®Google Scholar 79 Kennedy L, Walshe K, Hadden DR, Weaver JA, and Buchanan KD: The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with type 2 (non-insulin-dependent) diabetes mellitus: A prospective study. Diabetologia 23: 24–27, 1982. 10.1007/BF00257725 CASPubMedWeb of Science®Google Scholar 80 Taylor KG, John WG, Matthews KA, and Wright AD: A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes. Diabetologia 23: 507–510, 1982. 10.1007/BF00254300 PubMedWeb of Science®Google Scholar 81 Coulston AM, Hollenbeck CB, Swislocki ALM, Chen Y-DI, and Reaven GM: Deleterious metabolic effects of high-carbohydrate sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med 82: 213–220, 1987. 10.1016/0002-9343(87)90058-1 CASPubMedWeb of Science®Google Scholar 82 Paisey R, Elkeles RS, Hambley J, and Magil P: The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia 15: 81–85, 1978. 10.1007/BF00422249 CASPubMedWeb of Science®Google Scholar 83 Taskinen M-R, Beltz WF, Harper I, et al: Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: Studies before and after sulfonylurea therapy. Diabetes 35: 1268–1277, 1986. 10.2337/diabetes.35.11.1268 CASPubMedWeb of Science®Google Scholar 84 Argardh C-D, Nilsson-Ehle P, and Schersten B: Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus. Diabetes Care 5: 322–325, 1982. 10.2337/diacare.5.3.322 PubMedWeb of Science®Google Scholar 85 Rabkin SW, Boyko E, and Streja DA: Changes in high density lipoprotein cholesterol after initiation of insulin therapy in non-insulin dependent diabetes mellitus: Relationship to changes in body weight. Am J Med Sci 285: 14–201, 1983. 10.1097/00000441-198305000-00003 CASPubMedWeb of Science®Google Scholar 86 Stalenhoef AFH, Demacher PNM, Lutterman JA, and Van't Laar A: High-density-lipoprotein and maturity-onset diabetes. Lancet 1: 325, 1978. 10.1016/S0140-6736(78)90092-2 CASPubMedWeb of Science®Google Scholar 87 Hollenbeck CB, Chen Y-DI, Greenfield MS, Lardinois CK, and Reaven GM: Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 62: 605–608, 1986. 10.1210/jcem-62-3-605 CASPubMedWeb of Science®Google Scholar 88 Elkeles RS, Wu J, and Hambley J: Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetes: Lancet 2: 547–548, 1978. 10.1016/S0140-6736(78)92882-9 CASPubMedWeb of Science®Google Scholar 89 Yudkin JS, Boucher BJ, France MW, Welch SG, and Swindlehurst C: The relationship between concentrations of glycosylated haemoglobins and of serum high-density-lipoprotein cholesterol in diabetic patients. Clin Sci 56: 267–272, 1979. Google Scholar 90 Glasgow AM, August GP, and Wellington H: Relationship between control and serum lipids in juvenile-onset diabetes. Diabetes Care 4: 76–80, 1981. 10.2337/diacare.4.1.76 CASPubMedWeb of Science®Google Scholar 91 Vialettes B, Vovan L, Simon MC, Lassmann V, Altomare E, and Vague P: Kinetics of fast haemoglobin in diabetic rats. Diabetologia 22: 264–268, 1982. 10.1007/BF00281303 CASPubMedWeb of Science®Google Scholar 92 Sosenko JM, Breslow J, Miettinen OS, and Gabbay KH: Hyperglycemia and plasma lipid levels: Covariations in insulin-dependent diabetes. Diabetes Care 5: 40–43, 1982. 10.2337/diacare.5.1.40 CASPubMedWeb of Science®Google Scholar Citing Literature Volume3, Issue3July 1987Pages 653-668 ReferencesRelatedInformation
Referência(s)